论文部分内容阅读
肺癌是当今世界上对人类健康和生命危害极大的恶性肿瘤之一,化疗是肺癌的主要治疗手段。近年来新型高效的抗肿瘤药物问世,为探讨有效化疗方案提供了新的思路。我科自2001年1月起,采用多西紫杉醇联合吉西他滨每周给药方案治疗非小细胞肺癌(NSCLC)28例,取得较好疗效,现将结果报告如下:
Lung cancer is one of the most malignant tumors in human health and lives in the world today. Chemotherapy is the main treatment for lung cancer. In recent years, the advent of new and effective anti-cancer drugs, to explore effective chemotherapy programs provide a new way of thinking. Our department from January 2001 onwards, the docetaxel combined with gemcitabine weekly dosing regimen of non-small cell lung cancer (NSCLC) in 28 cases, and achieved good results, the results are reported as follows: